glp-1 market growth Receptor Agonist Size New Demand in an Old
Description
In your hands typically in 5-7 business days, if approved
A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications
GLP-1 meds with no insurance, no hidden fees
Enhancing Affordability: With branded Ozempic typically costing over C$200/month, the introduction of multiple generic options could lead to more competitive pricing, potentially making obesity care more accessible for many Canadians
Ghashghaei N et al
